Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OncoTherapy Science of Japan Plans Trials Soon On Biotech Cancer Vaccine (Japan)

This article was originally published in PharmAsia News

Executive Summary

Japan's OncoTherapy Science expects to begin clinical trials this spring on a new type of cancer vaccine that relies on injecting protein fragments. The biotech technique involves genetically coded proteins injected into patients to stimulate their immune systems to attack cancers. The company has identified 16 cancer-related genes and has synthesized protein fragments and made vaccines for all of them, including ones aimed at the bladder, esophagus and lungs. (Click here for more - may require a subscription



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts